Health Care & Life Sciences » Biotechnology | Eiger BioPharmaceuticals Inc.

Eiger BioPharmaceuticals Inc. | Key People and Executives

David A. Cory
President, Chief Executive Officer & Director
David Apelian
COO, Director & Executive Medical Officer
Thomas John Dietz
Independent Chairman
Eldon C. Mayer
Independent Director
Evan Loh
Independent Director
Jeffrey S. Glenn
Independent Director
David A. Cory
President, Chief Executive Officer & Director
David Apelian
COO, Director & Executive Medical Officer
James H. Welch
Chief Financial Officer
Lisa E. Porter
Chief Medical Officer
Debra A. Odink
Senior Vice President-Technical Operations
James P. Shaffer
Chief Business Officer
Ingrid C. Choong
Head-Investor Relations
Thomas John Dietz
Independent Chairman
Eldon C. Mayer
Independent Director
Evan Loh
Independent Director
Jeffrey S. Glenn
Independent Director

About Eiger BioPharmaceuticals

View Profile
Address
2155 Park Boulevard
Palo Alto California 94306
United States
Employees -
Website http://www.eigerbio.com
Updated 07/08/2019
Eiger BioPharmaceuticals, Inc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for orphan diseases. It focuses on product candidates for the treatment of orphan diseases such as Sarasar, Pegylated Interferon Lambda, Exendin 9-39, and Ubenimex. The company was founded by David A.